Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W H Frishman

Showing results (31-40 of 311) with videos related to

Pageof 32
Sort By:
The Mount Sinai Journal of Medicine, New York|March 1, 1990
Saving lives after myocardial infarction: the role of beta-adrenergic blockersW H Frishman
American Heart Journal|February 1, 1991
Clinical perspective on celiprolol: cardioprotective potentialW H Frishman
American Journal of Hypertension|March 1, 1997
Results of hypertension treatment with low-dose combinations of a beta-adrenergic blocker and a diureticW H Frishman
The American Journal of Medicine|July 31, 1998
Biologic markers as predictors of cardiovascular diseaseW H Frishman
The American Journal of Cardiology|June 19, 1998
William Howard Frishman, MD: a conversation with the editor. Interview by William Clifford RobertsW H Frishman
The American Journal of Cardiology|November 27, 1992
Tolerance, rebound, and time-zero effect of nitrate therapyW H Frishman
Heart Disease (Hagerstown, Md.)|December 1, 2001
Silent myocardial ischemia: is it a clinical entity that requires therapy?W H Frishman
Heart Disease (Hagerstown, Md.)|January 17, 2002
Angiotensin-converting enzyme inhibitors for the prevention and treatment of cardiovascular diseaseW H Frishman
Indian Heart Journal|January 7, 2000
CarvedilolW H Frishman
Heart Disease (Hagerstown, Md.)|November 27, 2001
Recent advances in cardiovascular pharmacologyW H Frishman
Pageof 32

Showing results (31-40 of 311) with videos related to

Sort By:
Pageof 32
The Mount Sinai Journal of Medicine, New York|March 1, 1990
Saving lives after myocardial infarction: the role of beta-adrenergic blockersW H Frishman
American Heart Journal|February 1, 1991
Clinical perspective on celiprolol: cardioprotective potentialW H Frishman
American Journal of Hypertension|March 1, 1997
Results of hypertension treatment with low-dose combinations of a beta-adrenergic blocker and a diureticW H Frishman
The American Journal of Medicine|July 31, 1998
Biologic markers as predictors of cardiovascular diseaseW H Frishman
The American Journal of Cardiology|June 19, 1998
William Howard Frishman, MD: a conversation with the editor. Interview by William Clifford RobertsW H Frishman
The American Journal of Cardiology|November 27, 1992
Tolerance, rebound, and time-zero effect of nitrate therapyW H Frishman
Heart Disease (Hagerstown, Md.)|December 1, 2001
Silent myocardial ischemia: is it a clinical entity that requires therapy?W H Frishman
Heart Disease (Hagerstown, Md.)|January 17, 2002
Angiotensin-converting enzyme inhibitors for the prevention and treatment of cardiovascular diseaseW H Frishman
Indian Heart Journal|January 7, 2000
CarvedilolW H Frishman
Heart Disease (Hagerstown, Md.)|November 27, 2001
Recent advances in cardiovascular pharmacologyW H Frishman
Pageof 32